Trial Profile
High dose and frequency Extended-release Lansoprazole (Dexlansoprazole) and Amoxicillin dual therapy for Helicobacter pylori infections
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Nov 2017
Price :
$35
*
At a glance
- Drugs Dexlansoprazole (Primary) ; Amoxicillin
- Indications Gastrointestinal disorders; Peptic ulcer
- Focus Therapeutic Use
- 15 Oct 2017 Status changed from recruiting to completed.
- 08 Sep 2016 New trial record